CTS
CTS
CTS CorporationIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $137.27M ▼ | $30.65M ▼ | $19.74M ▲ | 14.38% ▲ | $0.68 ▲ | $34.56M ▲ |
| Q3-2025 | $142.97M ▲ | $34.12M ▲ | $13.69M ▼ | 9.57% ▼ | $0.46 ▼ | $29.63M ▼ |
| Q2-2025 | $135.54M ▲ | $29.4M ▼ | $18.53M ▲ | 13.67% ▲ | $0.62 ▲ | $32.9M ▲ |
| Q1-2025 | $125.81M ▼ | $29.81M ▲ | $13.37M ▼ | 10.62% ▼ | $0.45 | $26.09M ▼ |
| Q4-2024 | $127.31M | $27.86M | $13.61M | 10.69% | $0.45 | $27.3M |
What's going well?
The company managed to grow profits and earnings per share sharply even as revenue declined. Operating margins improved, and cost discipline is strong, showing management can deliver results in a tough environment.
What's concerning?
Revenue is shrinking, which could be a warning sign if the trend continues. Gross profit also fell, and the company can't cut costs forever—eventually, sales need to grow for long-term health.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $82.3M ▼ | $764.31M ▼ | $212.53M ▼ | $551.79M ▲ |
| Q3-2025 | $110.3M ▲ | $790.37M ▲ | $242.72M ▲ | $547.65M ▼ |
| Q2-2025 | $99.44M ▲ | $784.73M ▲ | $234.57M ▲ | $550.16M ▲ |
| Q1-2025 | $90.29M ▼ | $765.53M ▼ | $227.29M ▼ | $538.24M ▲ |
| Q4-2024 | $94.33M | $766.11M | $235.26M | $530.85M |
What's financially strong about this company?
CTS has much more equity than debt, a long history of profits, and is actively buying back shares. Debt is being paid down and inventory is under control.
What are the financial risks or weaknesses?
Cash fell sharply this quarter and a third of assets are tied up in goodwill and intangibles, which could be written down if business weakens. Liquidity is still fine but trending tighter.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $19.74M ▲ | $29.21M ▲ | $-5.97M ▼ | $-51.03M ▼ | $-28M ▼ | $26.02M ▲ |
| Q3-2025 | $13.69M ▼ | $29.02M ▲ | $-4.8M ▼ | $-15.05M ▲ | $10.86M ▲ | $24.23M ▼ |
| Q2-2025 | $18.52M ▲ | $28.35M ▲ | $-3.28M ▲ | $-16.45M ▼ | $9.15M ▲ | $25.07M ▲ |
| Q1-2025 | $13.37M ▼ | $15.52M ▼ | $-4.46M ▲ | $-15.9M ▲ | $-4.05M ▼ | $11.05M ▼ |
| Q4-2024 | $13.61M | $25.95M | $-6.1M | $-20.44M | $-541K | $19.85M |
Revenue by Products
| Product | Q4-2012 | Q1-2013 | Q2-2013 | Q3-2013 |
|---|---|---|---|---|
Components And Sensors Segment | $80.00M ▲ | $100.00M ▲ | $110.00M ▲ | $100.00M ▼ |
Ems Segment | $0 ▲ | $50.00M ▲ | $50.00M ▲ | $60.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at CTS Corporation's financial evolution and strategic trajectory over the past five years.
CTS demonstrates a solid combination of improving profitability, strong and consistent cash generation, and a generally healthy balance sheet. Its competitive strengths lie in specialized sensing and actuation technologies, custom solutions, and long‑standing customer relationships across diversified end markets. Strategic acquisitions and a focused innovation agenda in electrification, automation, and healthcare further support its long‑term positioning.
Key risks include relatively flat revenue growth, rising overhead and debt levels, and a clear shift from net cash to net debt as the company funds acquisitions. Liquidity, while still strong, has weakened due to lower cash reserves. Competitive pressure from larger global electronics and sensor companies, rapid technology change, and the need to successfully integrate acquired businesses all introduce uncertainty. Modest growth in R&D spending also raises the question of whether the innovation pace will remain sufficient to stay ahead in fast‑moving markets.
The overall picture is of a company that has executed a strong earnings recovery, built a more diversified and defensible market position, and is actively investing for future growth through both internal innovation and acquisitions. Future performance will likely hinge on CTS’s ability to convert its innovation pipeline and recent acquisitions into sustained revenue growth, while carefully managing leverage, maintaining robust cash generation, and preserving its technological edge in the face of intense competition.
About CTS Corporation
https://www.ctscorp.comCTS Corporation manufactures and sells sensors, actuators, and connectivity components in North America, Europe, and Asia.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $137.27M ▼ | $30.65M ▼ | $19.74M ▲ | 14.38% ▲ | $0.68 ▲ | $34.56M ▲ |
| Q3-2025 | $142.97M ▲ | $34.12M ▲ | $13.69M ▼ | 9.57% ▼ | $0.46 ▼ | $29.63M ▼ |
| Q2-2025 | $135.54M ▲ | $29.4M ▼ | $18.53M ▲ | 13.67% ▲ | $0.62 ▲ | $32.9M ▲ |
| Q1-2025 | $125.81M ▼ | $29.81M ▲ | $13.37M ▼ | 10.62% ▼ | $0.45 | $26.09M ▼ |
| Q4-2024 | $127.31M | $27.86M | $13.61M | 10.69% | $0.45 | $27.3M |
What's going well?
The company managed to grow profits and earnings per share sharply even as revenue declined. Operating margins improved, and cost discipline is strong, showing management can deliver results in a tough environment.
What's concerning?
Revenue is shrinking, which could be a warning sign if the trend continues. Gross profit also fell, and the company can't cut costs forever—eventually, sales need to grow for long-term health.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $82.3M ▼ | $764.31M ▼ | $212.53M ▼ | $551.79M ▲ |
| Q3-2025 | $110.3M ▲ | $790.37M ▲ | $242.72M ▲ | $547.65M ▼ |
| Q2-2025 | $99.44M ▲ | $784.73M ▲ | $234.57M ▲ | $550.16M ▲ |
| Q1-2025 | $90.29M ▼ | $765.53M ▼ | $227.29M ▼ | $538.24M ▲ |
| Q4-2024 | $94.33M | $766.11M | $235.26M | $530.85M |
What's financially strong about this company?
CTS has much more equity than debt, a long history of profits, and is actively buying back shares. Debt is being paid down and inventory is under control.
What are the financial risks or weaknesses?
Cash fell sharply this quarter and a third of assets are tied up in goodwill and intangibles, which could be written down if business weakens. Liquidity is still fine but trending tighter.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $19.74M ▲ | $29.21M ▲ | $-5.97M ▼ | $-51.03M ▼ | $-28M ▼ | $26.02M ▲ |
| Q3-2025 | $13.69M ▼ | $29.02M ▲ | $-4.8M ▼ | $-15.05M ▲ | $10.86M ▲ | $24.23M ▼ |
| Q2-2025 | $18.52M ▲ | $28.35M ▲ | $-3.28M ▲ | $-16.45M ▼ | $9.15M ▲ | $25.07M ▲ |
| Q1-2025 | $13.37M ▼ | $15.52M ▼ | $-4.46M ▲ | $-15.9M ▲ | $-4.05M ▼ | $11.05M ▼ |
| Q4-2024 | $13.61M | $25.95M | $-6.1M | $-20.44M | $-541K | $19.85M |
Revenue by Products
| Product | Q4-2012 | Q1-2013 | Q2-2013 | Q3-2013 |
|---|---|---|---|---|
Components And Sensors Segment | $80.00M ▲ | $100.00M ▲ | $110.00M ▲ | $100.00M ▼ |
Ems Segment | $0 ▲ | $50.00M ▲ | $50.00M ▲ | $60.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at CTS Corporation's financial evolution and strategic trajectory over the past five years.
CTS demonstrates a solid combination of improving profitability, strong and consistent cash generation, and a generally healthy balance sheet. Its competitive strengths lie in specialized sensing and actuation technologies, custom solutions, and long‑standing customer relationships across diversified end markets. Strategic acquisitions and a focused innovation agenda in electrification, automation, and healthcare further support its long‑term positioning.
Key risks include relatively flat revenue growth, rising overhead and debt levels, and a clear shift from net cash to net debt as the company funds acquisitions. Liquidity, while still strong, has weakened due to lower cash reserves. Competitive pressure from larger global electronics and sensor companies, rapid technology change, and the need to successfully integrate acquired businesses all introduce uncertainty. Modest growth in R&D spending also raises the question of whether the innovation pace will remain sufficient to stay ahead in fast‑moving markets.
The overall picture is of a company that has executed a strong earnings recovery, built a more diversified and defensible market position, and is actively investing for future growth through both internal innovation and acquisitions. Future performance will likely hinge on CTS’s ability to convert its innovation pipeline and recent acquisitions into sustained revenue growth, while carefully managing leverage, maintaining robust cash generation, and preserving its technological edge in the face of intense competition.

CEO
Kieran M. O'Sullivan
Compensation Summary
(Year 2024)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 1999-08-13 | Forward | 2:1 |
| 1997-11-25 | Forward | 3:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 182
Ratings Snapshot
Rating : A-
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:4.78M
Value:$251.73M
BLACKROCK, INC.
Shares:4.45M
Value:$234.59M
VANGUARD GROUP INC
Shares:2.74M
Value:$144.51M
Summary
Showing Top 3 of 311

